← Leaderboards
Kent R Bailey
Mayo Clinic Coll Of Medicine, Rochester
$4,588,162
Attributed
$7,371,919
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,371,919 · 5
By mechanism
R01$4,679,581 · 2
U01$1,893,683 · 1
P01$654,155 · 1
R03$144,500 · 1
Top collaborators
- Virginia M Miller5 shared
- Whyte G Owen5 shared
- Aneel Ashrani4 shared
- John A Heit4 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Virginia M Miller$9,622,525
- John A Heit$17,456,146
- Walter A Rocca$16,950,554
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentCardiovascular DiseasesPreventionPreparationResearch StudySocietiesResponseThrombosisBasePersonsProteinsBlood PlateletsLeadAmericanBloodCoronaryPublishingPublic Health RelevanceRecurrencePrincipal InvestigatorIncidenceCessation Of LifeClinicClinical Practice
Grant awards (18)
Risk Factors for Venous Thromboembolism in the Community$694,657
R01 · FY2019 · HL
Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - DCC$283,386
U01 · FY2019 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$694,657
R01 · FY2018 · HL
Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - DCC$416,443
U01 · FY2018 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$694,655
R01 · FY2017 · HL
Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - DCC$551,640
U01 · FY2017 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$694,654
R01 · FY2016 · HL
Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - DCC$642,214
U01 · FY2016 · HL · contact PI
Estrogen, Platelets, and Artherosclerosis$375,275
R01 · FY2012 · HL
Estrogen, Platelets, and Artherosclerosis$376,457
R01 · FY2011 · HL
Estrogen, Platelets, and Artherosclerosis$387,948
R01 · FY2010 · HL
Estrogen, Platelets, and Artherosclerosis$378,300
R01 · FY2009 · HL
Estrogen, Platelets, and Artherosclerosis$382,978
R01 · FY2008 · HL
Core--Biostatistics$347,116
P01 · FY2005 · HL
Predicting Systolic BP Control in the Elderly$72,250
R03 · FY2003 · HL
Core--Biostatistics$307,039
P01 · FY2002 · HL
Predicting Systolic BP Control in the Elderly$72,250
R03 · FY2002 · HL
Core--Biostatistics$0
P01 · FY2001 · HL